Affiliation:
1. Medical Academy named after S.I. Georgievsky
2. Rostov State Medical University
3. Donetsk Clinical Territorial Medical Association
Abstract
Objective: study of associations between VDR gene rs1544410 and rs10735810 polymorphisms, MCM6 gene rs4988235, CALCR gene rs1801197 one and ibandronate efficacy in women with postmenopausal osteoporosis.Materials and methods: 117 women with postmenopausal osteoporosis were examined for 12 months in the dynamics of treatment with ibandronate. Evaluation of therapy effectiveness was based on indicators of increase in bone mineral density in L1-L4 lumbar vertebrae, as well as left and right femurs.Results: An association of GG genotype of VDR gene rs1544410 polymorphism with low growth rates of mineral density of L1-L4 lumbar vertebrae (3,41 ± 0,60 % versus 5,51 ± 0,78 % in other women; р = 0,036) was established. The effect of other studied polymorphisms (rs10735810 of VDR gene, rs4988235 of MCM6 gene, rs1801197 of CALCR gene) on treatment effectiveness was not found.Conclusion: it is advisable to use obtained results when developing personalized regimens for antiresorptive therapy for women with postmenopausal osteoporosis.
Publisher
Rostov State Medical University
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference21 articles.
1. Nikitinskaya O.A., Toroptsova N.V. Assessment of 10-year probability of osteoporotic fractures with the russian model of FRAX in a population-based sample 5 regions of Russia. Meditsinskij sovet. 2017;1S:103-107. (In Russ.) https://doi.org/10.21518/2079-701X-2017-0-103-107
2. Ukon Y, Makino T, Kodama J., Tsukazaki H, Tateiwa D. et al. Molecular-Based Treatment Strategies for Osteoporosis: A Literature Review. Int J Mol Sci. 2019;20(10). pii: E2557. https://doi.org/10.3390/ijms20102557.
3. Langdahl BL. Overview of treatment approaches to osteoporosis. Br. J. Pharmacol. 2020. Epub ahead of print. https://doi.org/10.1111/bph.15024
4. Zakharov I.S., Kolpinskiy G.I., Shalamanova N.V., Kolesnik I.Yu., Lebedeva T.V., Titarenko O.V. A comprehensive approach to the treatment of osteoporosis in the postmenopausal period in the context of international clinical guidelines. Consilium Medicum. 2019;21(6):50-53. (In Russ.) https://doi.org/10.26442/20751753.2019.6.190530
5. Mazurov VI, Lesnyak OM, Belova KYu, Ershova OB, Zotkin EG et al. Algorithm for selection of drug for osteoporosis treatment in primary care and in organization of provision with medicinal products of citizens eligible for state social assistance. Review of the literature and position of Russian Association on Osteoporosis Expert Council. The Russian Journal of Preventive Medicine. 2019;22(1):57-65. (In Russ.). https://doi.org/10.17116/profmed20192201157